MedTech Dive June 3, 2024
Pitchbook analysts are cautiously optimistic that the funding pickup will continue despite uncertainty about interest rates, heightened regulatory scrutiny and the presidential election.
Dive Brief:
- Venture capital investment in medtech rebounded in the first quarter, reaching the highest level since late 2022 even as deal counts remained historically low, according to a new report from market data research firm Pitchbook.
- Medtech M&A in the public market was subdued in the first quarter, with Boston Scientific’s $3.7 billion acquisition of neuromodulation maker Axonics standing out as one of the largest deals in the sector over the past year. Johnson & Johnson’s $13.1 billion purchase of Shockwave Medical, which closed last week, is now the industry’s largest deal of the year....
Today's Sponsors
Today's Sponsor